Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

Emma Bjorgum is the Vice President, Client Services, DNA in the Nucleic Acid Business Unit for Aldevron.

Emma has been working in the cell and gene therapy industry for over 10 years. Prior to her current position, Emma served as Director of Client Development at Aldevron. Her prior experience was at Millipore Sigma within the Viral and Gene Therapy Manufacturing business unit as a Business Development Manager. She also worked for Be The BioTherapies as a Business and Market Analyst, and started her career at Aldevron in Client Relations.

Emma holds a degree in Biology from Concordia College in Moorhead, MN

Also Speaking

Michael E. Meyers

Vice Chairman Head of M&A and Strategic Advisory Services • H.C. Wainwright & Co

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

David Chang

Chief Executive Officer • WuXi Advanced Therapies

Event Info


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.